Results 171 to 180 of about 28,572 (218)
, 2000 Some of the next articles are maybe not open access.
Related searches:
Related searches:
Burkholderia cepacia Sepsis Among Neonates
The Indian Journal of Pediatrics, 2014Burkholderia cepacia is a rare cause of sepsis in newborns and its transmission involves human contact with heavily contaminated medical devices and disinfectants. The authors aimed to determine epidemiology, clinical features, antibiotic sensitivity pattern, complications and outcome of blood culture proven B. cepacia infections in 12 neonates.
Saikat, Patra +6 more
openaire +2 more sources
Lipopolysaccharide chemotypes of Burkholderia cepacia
Journal of Medical Microbiology, 1999Burkholderia cepacia is an important pathogen in patients with cystic fibrosis (CF) and much is now known of its epidemiology. In contrast, its virulence mechanisms are poorly understood. The lipopolysaccharide (LPS) of B. cepacia, a well-recognised virulence factor of other gram-negative bacteria, is known to be strongly endotoxic in vitro. The aim of
Elwyn, Evans +2 more
openaire +2 more sources
BURKHOLDERIA CEPACIA ENDOPHTHALMITIS
Retina, 2011To report the clinical presentations, antibiotic sensitivities, and outcomes of Burkholderia cepacia endophthalmitis.Retrospective, consecutive, noncomparative, interventional case series. We reviewed case records of culture-proven B. cepacia endophthalmitis from the endophthalmitis registry between January 2003 and December 2008.
Virender, Sachdeva +4 more
openaire +2 more sources
The multifarious, multireplicon Burkholderia cepacia complex
Nature Reviews Microbiology, 2005The Burkholderia cepacia complex (Bcc) is a collection of genetically distinct but phenotypically similar bacteria that are divided into at least nine species. Bcc bacteria are found throughout the environment, where they can have both beneficial and detrimental effects on plants and some members can also degrade natural and man-made pollutants.
Eshwar, Mahenthiralingam +2 more
openaire +2 more sources
Advances in Burkholderia cepacia complex
Paediatric Respiratory Reviews, 2002Burkholderia cepacia is an important opportunistic pathogen in certain compromised hosts, particularly those with either cystic fibrosis (CF) or chronic granulomatous disease. The "family" of bacteria known as B. cepacia is highly heterogeneous and is composed of at least nine discrete species or genomovars, constituting the B.
openaire +2 more sources
Burkholderia cepacia infection and lung transplantation
Seminars in Respiratory Infections, 2002Burkholderia cepacia has emerged as an important pathogen in patients with cystic fibrosis (CF) undergoing lung transplantation. Taxonomic analyses have divided B. cepacia into 7 closely related species called genomovars. The prevalence of B. cepacia infection ranges from 2% to 13% in CF patients with genomovar III being most prevalent.
Shahid, Husain, Nina, Singh
openaire +2 more sources
Burkholderia cepaciain Cystic Fibrosis
New England Journal of Medicine, 1995Variable clinical course has been reported with the acquisition of Burkholderia cepacia in patients who have cystic fibrosis (CF). We hypothesized that the perceived worsening with B. cepacia may reflect the underlying severity of pulmonary disease at the time of acquisition. To test this hypothesis, we matched CF patients colonized with B.
E, Mahenthiralingam +2 more
openaire +2 more sources
Burkholderia cepacia: This Decision Is Overdue
PDA Journal of Pharmaceutical Science and Technology, 2011This is the third in a series of seven articles discussing the Recall Root Cause Research project conducted by the Division of Manufacturing and Product Quality, Center for Drug Evaluation and Research. This paper reviews the regulatory and scientific impact of a common and recurring opportunistic pathogen, Burkholderia cepacia. B. cepacia is comprised
Lynn, Torbeck +4 more
openaire +2 more sources